Revenue · 2011–2025
Vanda Pharmaceuticals revenue
$216M+8.7% · FY2025
Vanda Pharmaceuticals (VNDA) reported $216M in revenue for fiscal 2025, +8.7% year on year.
| Fiscal year | Revenue | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $216M | +8.7% | Open → |
| FY20242024-12-31 | $199M | +3.2% | Open → |
| FY20232023-12-31 | $193M | −24.3% | Open → |
| FY20222022-12-31 | $254M | −5.3% | Open → |
| FY20212021-12-31 | $269M | +8.3% | Open → |
| FY20202020-12-31 | $248M | +9.2% | Open → |
| FY20192019-12-31 | $227M | +17.6% | Open → |
| FY20182018-12-31 | $193M | +17.0% | Open → |
| FY20172017-12-31 | $165M | +13.1% | Open → |
| FY20162016-12-31 | $146M | +32.8% | Open → |
| FY20152015-12-31 | $110M | +119.2% | Open → |
| FY20142014-12-31 | $50.2M | +48.0% | Open → |
| FY20132013-12-31 | $33.9M | +3.5% | Open → |
| FY20122012-12-31 | $32.7M | +4.7% | Open → |
| FY20112011-12-31 | $31.3M | — | Open → |
Revenue — Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +14.8%
Revenue at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Vanda Pharmaceuticals revenue |url=https://companiesranked.com/en/company/vanda-pharmaceuticals/revenue |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Vanda Pharmaceuticals revenue. CompaniesRanked. https://companiesranked.com/en/company/vanda-pharmaceuticals/revenueBibTeX
@misc{companiesranked-en-company-vanda-pharmaceuticals-revenue-2026,
author = {{CompaniesRanked}},
title = {{Vanda Pharmaceuticals revenue}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/vanda-pharmaceuticals/revenue}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001628280-26-007460 · February 12, 2026
{{cite web |title=Vanda Pharmaceuticals revenue — 10-K (0001628280-26-007460) |url=https://www.sec.gov/Archives/edgar/data/1347178/000162828026007460/vnda-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-12}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.